These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8708744)

  • 1. An open, multicenter clinical trial of piperacillin/tazobactam in the treatment of pediatric patients with intra-abdominal infections.
    Arguedas A; Sifuentes-Osornio J; Loaiza C; Herrera M; Corrales JC; Mohs E
    J Chemother; 1996 Apr; 8(2):130-6. PubMed ID: 8708744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
    Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults.
    Namias N; Solomkin JS; Jensen EH; Tomassini JE; Abramson MA
    Surg Infect (Larchmt); 2007 Feb; 8(1):15-28. PubMed ID: 17381394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
    Solomkin JS; Yellin AE; Rotstein OD; Christou NV; Dellinger EP; Tellado JM; Malafaia O; Fernandez A; Choe KA; Carides A; Satishchandran V; Teppler H;
    Ann Surg; 2003 Feb; 237(2):235-45. PubMed ID: 12560782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
    Sweet RL; Roy S; Faro S; O'Brien WF; Sanfilippo JS; Seidlin M
    Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
    Ohlin B; Cederberg A; Forssell H; Solhaug JH; Tveit E
    Eur J Surg; 1999 Sep; 165(9):875-84. PubMed ID: 10533765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections.
    Shyr YM; Lui WY; Su CH; Wang LS; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Aug; 56(2):102-8. PubMed ID: 7553416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperacillin/tazobactam in the treatment of hospitalized patients with urinary tract infections: an open non-comparative and multicentered trial.
    Sifuentes-Osornio J; Jakob E; Clara L; Durlach R; Dain A; Ruìz-Palacios GM; Barkan L; Lamberghini R; Jáuregui A; Villalobos Y; Sáenz-Aguirre C; de la Cabada FJ; Rodríguez-Toledo A; Zavala-Trujillo I; Gamboa MA; Fuentes del Toro S; Froiler C; Maglio F; Quiroga JV; Rojas JJ; Conde-Carmona I
    J Chemother; 1996 Apr; 8(2):122-9. PubMed ID: 8708743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
    Vestweber KH; Grundel E
    Eur J Surg Suppl; 1994; (573):57-60. PubMed ID: 7524797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field].
    Shinagawa N; Yura J; Mashita K; Matsuno S; Rikiyama T; Hirayama T; Tanaka T; Otsuka K; Iwai S; Nakagawa Y
    Jpn J Antibiot; 1995 Mar; 48(3):346-67. PubMed ID: 7752449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
    Tellado J; Woods GL; Gesser R; McCarroll K; Teppler H
    Surg Infect (Larchmt); 2002; 3(4):303-14. PubMed ID: 12697078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of patients with intra-abdominal infection.
    Erasmo AA; Crisostomo AC; Yan LN; Hong YS; Lee KU; Lo CM
    Asian J Surg; 2004 Jul; 27(3):227-35. PubMed ID: 15564167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.
    Dela Pena AS; Asperger W; Köckerling F; Raz R; Kafka R; Warren B; Shivaprakash M; Vrijens F; Giezek H; DiNubile MJ; Chan CY;
    J Gastrointest Surg; 2006 Apr; 10(4):567-74. PubMed ID: 16627223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections.
    Mouton Y; Leroy O; Beuscart C; Chidiac C; Senneville E; Ajana F; Lecocq P
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():87-95. PubMed ID: 8383658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety evaluation of piperacillin/tazobactam in very low birth weight infants.
    Berger A; Kretzer V; Apfalter P; Rohrmeister K; Zaknun D; Pollak A
    J Chemother; 2004 Apr; 16(2):166-71. PubMed ID: 15216952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center.
    Siami FS; LaFleur BJ; Siami GA
    Clin Ther; 2002 Jan; 24(1):59-72. PubMed ID: 11833836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study.
    Graham DR; Lucasti C; Malafaia O; Nichols RL; Holtom P; Perez NQ; McAdams A; Woods GL; Ceesay TP; Gesser R
    Clin Infect Dis; 2002 Jun; 34(11):1460-8. PubMed ID: 12015692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoeconomics of ciprofloxacin plus metronidazole vs. piperacillin-tazobactam for complicated intra-abdominal infections.
    Paladino JA; Gilliland-Johnson KK; Adelman MH; Cohn SM
    Surg Infect (Larchmt); 2008 Jun; 9(3):325-33. PubMed ID: 18570574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.
    Solomkin J; Teppler H; Graham DR; Gesser RM; Meibohm AR; Roy S; Woods GL
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii51-7. PubMed ID: 15150183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience.
    Castagnola E; Bandettini R; Ginocchio F; Perotti M; Masa DL; Ciucci A; Loy A; Caviglia I; Haupt R; Guida E; Pini Prato A; Mattioli G; Buffa P
    J Chemother; 2013 Aug; 25(4):213-6. PubMed ID: 23906074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.